2022-RA-1387-ESGO Patients with minimal residual disease at upfront debulking surgery have similar survival outcome than patients with complete cytorreduction after neoadjuvant chemotherapy

Autor:	Violeta Romero, Martina Aida Angeles, Elena Rodriguez Gonzalez, Anne Sophie Navarro, Emmanuela Spagnolo, Asunción Pérez-Benavente, Bastien Cabarrou, Guillaume Bataillon, Federico Migliorelli, Agnieszka Rychlik, Frédéric Guyon, Sarah Bétrian, Antonio Gil-Moreno, Gwénaël Ferron, Alicia Hernández, Alejandra Martínez
Rok vydání:	2022
Zdroj:	Ovarian cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::eeeb54fef39ad32e6f1c4e90657af4c9 https://doi.org/10.1136/ijgc-2022-esgo.703 Zobrazit plný text záznamu